The newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday.
BEIJING, Nov. 29 (Xinhua) -- A 58-year-old man surnamed Li, weighing nearly 100 kg, was among the first patients in China to use Semaglutide as a prescribed medication for weight loss. Semaglutide is no stranger to Li, who has previously used it in another drug to manage his blood su...
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its tirzepatide medication, which is branded as Mounjaro for diabetes, under a new brand for weight loss as well. While Mounjaro had already been used by some patients "off-label" for weight lo...
In the past year, Eli Lilly is up 90%, while Novo Nordisk has gained 68%, as of Friday's market close. Mazza waived concerns that investors have missed out on the rally, noting the weight loss drug industry is still in its "early days." "The mar...
A survey of more than 1000 random US adults run during July 2023 shows that 49% had at least some interest in taking a safe, effective weight loss drug, or were already using one.
Scientists at the University of Copenhagen have discovered a new weight loss drug target that reduces appetite, increases energy expenditure, and improves insulin sensitivity without causing nausea or loss of muscle mass. The discovery was reported in th
Researchers presented data on a new crop of hormone analogues for weight loss—including an oral version of the blockbuster drug semaglutide—at the American Diabetes Association (ADA) 83rd annual Scientific Sessions program, held in June in San Diego. After the meeting wrapped, Robert Ga...
Drugwonks.com is the web log of the Center for Medicine in the Public Interest (CMPI), a forum offering rigorous and compelling research on the most critical issues affecting current drug policy. Submit Latest Drugwonks' Blog End the IRA’s Innovation-Killing “Big Payor” Bailout 01.28....
The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as obese.#The weight loss drug semaglutide (Wegovy) is now approved for pediatric patients ages 12 and older whose body mass index categorizes them as ...
John Simon, a teenager who had a bariatric surgery in 2022, cooks dinner for his family in Los Angeles on March 13, 2023. Jae C. Hong / AP In Minnesota, Edward Kent was diagnosed with fatty liver disease. The 6-foot, 300-pound high school sophomore started using the obesity drug ...